13G Filing: Weiss Asset Management and Nutraceutical International Corp (NUTR)

Page 1 of 12

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
WEISS ASSET MANAGEMENT 0 809,587 809,587 8.76%
BIP GP 0 155,679 155,679 1.68%
CMI GP 0 558,491 558,491 6.04%
WAM GP 0 809,587 809,587 8.76%
ANDREW M. WEISS, PH.D. 0 809,587 809,587 8.76%

Follow Andrew Weiss's Weiss Asset Management

Page 1 of 12 – SEC Filing




                                 UNITED STATES                                 

                      SECURITIES AND EXCHANGE COMMISSION                       

                            WASHINGTON, D.C. 20549                             


                                 SCHEDULE 13G                                  


                   Under the Securities Exchange Act of 1934                   

                               (Amendment No. _)*                             



Nutraceutical International Corporation


                               (Name of Issuer)                                



Common stock


                        (Title of Class of Securities)                         





                                (CUSIP Number)                                 



August 4, 2017


            (Date of Event Which Requires Filing of This Statement)            


Check the appropriate box to designate the rule pursuant to which this Schedule

is filed:                  

                            [ ] Rule 13d-1(b)                                  

                            [X] Rule 13d-1(c)                                  

                            [ ] Rule 13d-1(d)                                  


* The remainder of this cover page shall be filled out for a reporting person’s

initial filing on this form with respect to the subject class of securities, and

for any subsequent   amendment   containing   information  which  would  alter

disclosures provided in a prior cover page.                                     


The information required on the remainder of this cover page shall not be deemed

to be “filed” for the purpose of Section 18 of the  Securities  Exchange  Act of

1934 (“Act”) or otherwise subject to the liabilities of that section of the Act

but shall be  subject  to all other  provisions  of the Act  (however, see the


Follow Nutraceutical International Corp (NASDAQ:NUTR)

Page 1 of 12